BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.270
+0.160 (14.41%)
At close: Feb 13, 2026, 4:00 PM EST
1.350
+0.080 (6.30%)
After-hours: Feb 13, 2026, 7:57 PM EST
BioVie Market Cap
BioVie has a market cap or net worth of $9.58 million as of February 13, 2026. Its market cap has decreased by -67.76% in one year.
Market Cap
9.58M
Enterprise Value
-10.65M
1-Year Change
-67.76%
Ranking
Category
Stock Price
$1.27
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $9.58M, a decrease of -81.58%. That is a compound annual growth rate of -26.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 9.60M | 10.34% |
| Dec 31, 2025 | 8.70M | -75.49% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 9.60M |
| NuCana | 9.28M |
| Edesa Biotech | 9.17M |
| CollPlant Biotechnologies | 9.02M |
| TransCode Therapeutics | 8.88M |
| Evogene | 8.75M |
| BiomX | 8.75M |
| Pulmatrix | 8.73M |